MDSpire - Summary
From the Journals

BMI Patterns in ILD Outcomes Examined

Meta-analysis links higher body mass index to lower mortality and slower lung function decline in interstitial lung disease

Share

A systematic review of 25 articles and 29 studies involving 23,741 patients has revealed that a higher body mass index (BMI) correlates with reduced mortality and slower decline in lung function among individuals with interstitial lung disease (ILD). The analysis covered mortality rates, hospitalization, and lung function specifics from multiple databases through May 2024. It found that obese patients exhibited lower mortality rates and a slower decline in forced vital capacity, though limitations in study design and generalizability were noted. Such findings suggest BMI may reflect overall health rather than serve as a therapeutic target.

Original Source(s)

BMI Patterns in ILD Outcomes Examined

  • by Kathryn Wighton

  • April 1, 2026

Related Content

FDA Broadens CFTR Therapy Eligibility

The FDA expanded use of CFTR modulators to include more CF gene variants, increasing treatment eligibility across a wider US patient population.

Airway Resistome Higher In Chronic Lung Disease

Recent antibiotic exposure was linked to greater antimicrobial resistance gene burden in bronchoscopy samples of patients with chronic lung disease.

Ultrasound Models Estimate Whole-Body Muscle Mass

New equations incorporating cross-sectional area improve estimation accuracy.